Title:
Design, Synthesis and Pharmacological Evaluation of Noscapine Glycoconjugates

dc.contributor.authorKunj B Mishra
dc.contributor.authorNeeraj Tiwari
dc.contributor.authorPriyanka Bose
dc.contributor.authorRajan Singh
dc.contributor.authorArun K Rawat
dc.contributor.authorSumit K. Singh
dc.contributor.authorRam C. Mishra
dc.contributor.authorRakesh K Singh
dc.contributor.authorVinod K. Tiwari
dc.date.accessioned2026-02-07T09:06:33Z
dc.date.issued2019
dc.description.abstractThe present work is directed to design a series of molecules which are hybrids of two non-toxic biocompatible chemical architectures, noscapine and carbohydrates. Fourteen, 7-O-noscapine analogues have been synthesized out of which one of the analogue is 7-O-propargylated derivative and others are in its glycoconjugate form with triazole bridging achieved via Click reaction, where dinuclear copper(I) thiodiacetate complex [(PPh 3 ) 2 Cu(μ-tda)Cu(PPh 3 ) 2 ].6H 2 O has been emerged as an excellent catalyst for the noscapine-glyco Click-coupling. All the developed noscapine glycoconjugates have been investigated for anticancer activity using HeLa cell line and anti-leishmanial activity against Leishmania donovani. Result indicates that five of the developed noscapine glycoconjugates (5 a, 5 b, 5 c, 5 e and 5 l) showed significant anti-proliferative activity. On the other hand, four of them (5 b, 5 c, 5 e, and 5 l) showed significant anti-leishmanial activity. © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
dc.identifier.doi10.1002/slct.201803588
dc.identifier.issn23656549
dc.identifier.urihttps://doi.org/10.1002/slct.201803588
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/33974
dc.publisherWiley-Blackwell
dc.subjectAnti-cancer
dc.subjectAnti-leishmanial
dc.subjectClick chemistry
dc.subjectGlycoconjugates
dc.subjectNoscapine
dc.titleDesign, Synthesis and Pharmacological Evaluation of Noscapine Glycoconjugates
dc.typePublication
dspace.entity.typeArticle

Files

Collections